Renal neurohormonal regulation in heart failure decompensation

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 307, Issue 5, 2014, Pages

  Jönsson, Sofia ^a   Agic, Mediha Becirovic ^a   Narfström, Fredrik ^a   Melville, Jacqueline M ^a   Hultström, Michael ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Acute renal failure; ADHF; Cardiorenal syndrome; GFR; Glomerular filtration rate

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; ALDOSTERONE; ANGIOTENSIN; ENDOTHELIN; ICOSANOID; NATRIURETIC FACTOR; NEUROHORMONE; PURINE; RENIN; VASOPRESSIN;

ACUTE KIDNEY FAILURE; DISEASE EXACERBATION; FLUID RETENTION; HEART FAILURE; HORMONAL REGULATION; HUMAN; HYPOXIA; KIDNEY; KIDNEY PERFUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SYMPATHETIC NERVE; WATER RETENTION;

ACUTE RENAL FAILURE; ADHF; CARDIORENAL SYNDROME; GFR; GLOMERULAR FILTRATION RATE;

ACUTE KIDNEY INJURY; ANIMALS; CARDIAC OUTPUT; HEART FAILURE; HUMANS; KIDNEY; NEUROTRANSMITTER AGENTS; SIGNAL TRANSDUCTION; SYMPATHETIC NERVOUS SYSTEM; WATER-ELECTROLYTE BALANCE;

EID: 84907335437     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00178.2014     Document Type: Review

References (72)

1. Arima S, Kohagura K, Xu HL, Sugawara A, Uruno A, Satoh F, Takeuchi K, Ito S. Endothelium-derived nitric oxide modulates vascular action of aldosterone in renal arteriole. Hypertension 43: 352-357, 2004.
2. Bergdahl A, Valdemarsson S, Pantev E, Ottosson A, Feng QP, Sun XY, Hedner T, Edvinsson L. Modulation of vascular contractile responses to alpha 1-and alpha 2-adrenergic and neuropeptide Y receptor stimulation in rats with ischaemic heart failure. Acta Physiol Scand 154: 429-437, 1995.
3. Brond L, Mullertz KM, Torp M, Nielsen J, Graebe M, Hadrup N, Nielsen S, Christensen S, Jonassen TE. Congestive heart failure in rats is associated with increased collecting duct vasopressin sensitivity and vasopressin type 2 receptor reexternalization. Am J Physiol Renal Physiol 305: F1547-F1554, 2013.
4. Brown R, Ollerstam A, Johansson B, Skott O, Gebre-Medhin S, Fredholm B, Persson AE. Abolished tubuloglomerular feedback and increased plasma renin in adenosine A1 receptor-deficient mice. Am J Physiol Regul Integr Comp Physiol 281: R1362-R1367, 2001.
5. Butler J, Ezekowitz JA, Collins SP, Givertz MM, Teerlink JR, Walsh MN, Albert NM, Westlake Canary CA, Carson PE, Colvin-Adams M, Fang JC, Hernandez AF, Hershberger RE, Katz SD, Rogers JG, Spertus JA, Stevenson WG, Sweitzer NK, Tang WH, Stough WG, Starling RC. Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines Committee. J Card Fail 18: 265-281, 2012.
6. Cannon PJ. Prostaglandins in congestive heart failure and the effects of nonsteroidal anti-inflammatory drugs. Am J Med 81: 123-132, 1986.
7. Chaudhry SI, McAvay G, Chen S, Whitson H, Newman AB, Krumholz HM, Gill TM. Risk factors for hospital admission among older persons with newly diagnosed heart failure: findings from the Cardiovascular Health Study. J Am Coll Cardiol 61: 635-642, 2013.
8. Coats J. Wie ändern sich durch die Erregung des n. vagus die Arbeit und die innern Reize des Herzens? Druck von Breitkopf und Härtel, 1869.
9. Cruz DN, Schmidt-Ott KM, Vescovo G, House AA, Kellum JA, Ronco C, McCullough PA. Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 182: 117-136, 2013.
10. Dahl TD, Hultstrom M, Iversen BM, Helle F. Adenosine sensitization after angiotensin II stimulation in afferent arterioles from normal rats does not occur during two-kidney, one-clip hypertension. Acta Physiol (Oxf) 201: 289-294, 2011.
11. DiBona GF, Sawin LL. Role of renal alpha 2-adrenergic receptors in spontaneously hypertensive rats. Hypertension 9: 41-48, 1987.
12. Fan F, Sun CW, Maier KG, Williams JM, Pabbidi MR, Didion SP, Falck JR, Zhuo J, Roman RJ. 20-Hydroxyeicosatetraenoic acid contributes to the inhibition of K channel activity and vasoconstrictor response to angiotensin II in rat renal microvessels. PLos One 8: e82482, 2013.
13. Fenton RA. Essential role of vasopressin-regulated urea transport processes in the mammalian kidney. Pflügers Arch 458: 169-177, 2009.
14. Fenton RA, Flynn A, Shodeinde A, Smith CP, Schnermann J, Knepper MA. Renal phenotype of UT-A urea transporter knockout mice. J Am Soc Nephrol 16: 1583-1592, 2005.
15. Francis B, Winaver J, Karram T, Hoffman A, Abassi Z. Renal and systemic effects of chronic blockade of ET(A) or ET(B) receptors in normal rats and animals with experimental heart failure. J Cardiovasc Pharmacol 44(Suppl 1): S54-S58, 2004.
16. Francis BN, Abassi Z, Heyman S, Winaver J, Hoffman A. Differential regulation of ET(A) and ET(B) in the renal tissue of rats with compensated and decompensated heart failure. J Cardiovasc Pharmacol 44(Suppl 1): S362-S365, 2004.
17. Frank O. Zur Dynamik des Herzmuskels. Druck v. R. Oldenbourg, 1895.
18. Friederich-Persson M, Thorn E, Hansell P, Nangaku M, Levin M, Palm F. Kidney hypoxia, attributable to increased oxygen consumption, induces nephropathy independently of hyperglycemia and oxidative stress. Hypertension 62: 914-919, 2013.
19. Fu Y, Hall JE, Lu D, Lin L, Manning RD Jr, Cheng L, Gomez-Sanchez CE, Juncos LA, Liu R. Aldosterone blunts tubuloglomerular feedback by activating macula densa mineralocorticoid receptors. Hypertension 59: 599-606, 2012.
20. Gill JR Jr, Casper AG. Role of the sympathetic nervous system in the renal response to hemorrhage. J Clin Invest 48: 915-922, 1969.
21. Gottlieb SS, Skettino SL, Wolff A, Beckman E, Fisher ML, Freudenberger R, Gladwell T, Marshall J, Cines M, Bennett D, Liittschwager EB. Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure. J Am Coll Cardiol 35: 56-59, 2000.
22. Helle F, Hultstrom M, Skogstrand T, Palm F, Iversen BM. Angiotensin II-induced contraction is attenuated by nitric oxide in afferent arterioles from the nonclipped kidney in 2K1C. Am J Physiol Renal Physiol 296: F78-F86, 2009.
23. Hultstrom M. Neurohormonal interactions on the renal oxygen delivery and consumption in haemorrhagic shock-induced acute kidney injury. Acta Physiol 209: 11-25, 2013.
24. Hultstrom M, Helle F, Iversen BM. AT(1) receptor activation regulates the mRNA expression of CAT1, CAT2, arginase-1, and DDAH2 in preglomerular vessels from angiotensin II hypertensive rats. Am J Physiol Renal Physiol 297: F163-F168, 2009.
25. Hultstrom M, Lai EY, Ma Z, Kallskog O, Patzak A, Persson AE. Adenosine triphosphate increases the reactivity of the afferent arteriole to low concentrations of norepinephrine. Am J Physiol Regul Integr Comp Physiol 293: R2225-R2231, 2007.
26. Ikenaga H, Ishii N, Didion SP, Zhang K, Cornish KG, Patel KP, Mayhan WG, Carmines PK. Suppressed impact of nitric oxide on renal arteriolar function in rats with chronic heart failure. Am J Physiol Renal Physiol 276: F79-F87, 1999.
27. Iversen BM, Arendshorst WJ. ANG II and vasopressin stimulate calcium entry in dispersed smooth muscle cells of preglomerular arterioles. Am J Physiol Renal Physiol 274: F498-F508, 1998.
28. Jensen KT, Eiskjaer H, Carstens J, Pedersen EB. Renal effects of brain natriuretic peptide in patients with congestive heart failure. Clin Sci 96: 5-15, 1999.
29. Kemp BA, Bell JF, Rottkamp DM, Howell NL, Shao W, Navar LG, Padia SH, Carey RM. Intrarenal angiotensin III is the predominant agonist for proximal tubule angiotensin type 2 receptors. Hypertension 60: 387-395, 2012.
30. Kohan DE. Endothelin and collecting duct sodium and water transport. Contribut Nephrol 172: 94-106, 2011.
31. Koida S, Ohyanagi M, Ueda A, Mori Y, Iwasaka T. Mechanism of increased alpha-adrenoceptor-mediated contraction in small resistance arteries of rats with heart failure. Clin Exptl Pharmacol Physiol 33: 47-52, 2006.
32. Kon V, Yared A, Ichikawa I. Role of renal sympathetic nerves in mediating hypoperfusion of renal cortical microcirculation in experimental congestive heart failure and acute extracellular fluid volume depletion. J Clin Invest 76: 1913-1920, 1985.
33. Kopp UC, Cicha MZ, Jones SY. Activation of endothelin A receptors contributes to impaired responsiveness of renal mechanosensory nerves in congestive heart failure. Can J Physiol Pharmacol 88: 622-629, 2010.
34. Kopp UC, DiBona GF. Neural regulation of renin secretion. Seminars Nephrol 13: 543-551, 1993.
35. Kowalski R, Kreft E, Kasztan M, Jankowski M, Szczepanska-Konkel M. Chronic renal denervation increases renal tubular response to P2X receptor agonists in rats: implication for renal sympathetic nerve ablation. Nephrol Dial Transplant 27: 3443-3448, 2012.
36. Lai EY, Martinka P, Fahling M, Mrowka R, Steege A, Gericke A, Sendeski M, Persson PB, Persson AE, Patzak A. Adenosine restores angiotensin II-induced contractions by receptor-independent enhancement of calcium sensitivity in renal arterioles. Circ Res 99: 1117-1124, 2006.
37. Li Y, Yamada H, Kita Y, Kunimi M, Horita S, Suzuki M, Endo Y, Shimizu T, Seki G, Fujita T. Roles of ERK and cPLA2 in the angiotensin II-mediated biphasic regulation of Na-HCO3(-) transport. J Am Soc Nephrol 19: 252-259, 2008.
38. Liu JL, Zucker IH. Regulation of sympathetic nerve activity in heart failure: a role for nitric oxide and angiotensin II. Circ Res 84: 417-423, 1999.
39. Loffing J, Korbmacher C. Regulated sodium transport in the renal connecting tubule (CNT) via the epithelial sodium channel (ENaC). Pflügers Arch 458: 111-135, 2009.
40. Luk JK, Wong EF, Wong NL. Second messenger changes of atrial natriuretic factor and brain natriuretic peptide in kidneys of cardiomyopathic hamsters. Cardiology 85: 82-87, 1994.
41. Mann JF, Green D, Jamerson K, Ruilope LM, Kuranoff SJ, Littke T, Viberti G, Group AS. Avosentan for overt diabetic nephropathy. J Am Soc Nephrol 21: 527-535, 2010.
42. Margulies KB, Burnett JC Jr. Atrial natriuretic factor modulates whole kidney tubuloglomerular feedback. Am J Physiol Regul Integr Comp Physiol 259: R97-R101, 1990.
43. Marques RD, de Bruijn PI, Sorensen MV, Bleich M, Praetorius HA, Leipziger J. Basolateral P2X receptors mediate inhibition of NaCl transport in mouse medullary thick ascending limb (mTAL). Am J Physiol Renal Physiol 302: F487-F494, 2012.
44. Mironova E, Bugaj V, Roos KP, Kohan DE, Stockand JD. Aldosterone-independent regulation of the epithelial Na channel (ENaC) by vasopressin in adrenalectomized mice. Proc Natl Acad Sci USA 109: 10095-10100, 2012.
45. Moe GW, Grima EA, Angus C, Wong NL, Hu DC, Howard RJ, Armstrong PW. Response of atrial natriuretic factor to acute and chronic increases of atrial pressures in experimental heart failure in dogs. Role of changes in heart rate, atrial dimension, and cardiac tissue concentration. Circulation 83: 1780-1787, 1991.
46. Mukaddam-Daher S, Jankowski M, Dam TV, Quillen EW Jr, Gutkowska J. Renal atrial natriuretic factor receptors in hamster cardiomyopathy. Kidney Int 48: 1875-1885, 1995.
47. Myers BD, Deen WM, Brenner BM. Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule fluid reabsorption in the rat. Circ Res 37: 101-110, 1975.
48. Navar LG. Intrarenal renin-angiotensin system in regulation of glomerular function. Curr Opin Nephrol Hypertens 23: 38-45, 2014.
49. Packer M. Interaction of prostaglandins and angiotensin II in the modulation of renal function in congestive heart failure. Circulation 77: I64-I73, 1988.
50. Patterson SW, Starling EH. On the mechanical factors which determine the output of the ventricles. J Physiol 48: 357-379, 1914.
51. Phelan D, Thavendiranathan P, Collier P, Marwick TH. Aldosterone antagonists improve ejection fraction and functional capacity independently of functional class: a meta-analysis of randomised controlled trials. Heart 98: 1693-1700, 2012.
52. Ramchandra R, Hood SG, Frithiof R, May CN. Discharge properties of cardiac and renal sympathetic nerves and their impaired responses to changes in blood volume in heart failure. Am J Physiol Regul Integr Comp Physiol 297: R665-R674, 2009.
53. Ren Y, Garvin JL, Liu R, Carretero OA. Role of macula densa adenosine triphosphate (ATP) in tubuloglomerular feedback. Kidney Int 66: 1479-1485, 2004.
54. Riegger GA, Elsner D, Kromer EP. Circulatory and renal control by prostaglandins and renin in low cardiac output in dogs. Am J Physiol Heart Circ Physiol 256: H1079-H1086, 1989.
55. Ronco C, McCullough PA, Chawla LS. Kidney attack versus heart attack: evolution of classification and diagnostic criteria. Lancet 382: 939-940, 2013.
56. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med 341: 577-585, 1999.
57. Shao W, Seth DM, Prieto MC, Kobori H, Navar LG. Activation of the renin-angiotensin system by a low-salt diet does not augment intratubular angiotensinogen and angiotensin II in rats. Am J Physiol Renal Physiol 304: F505-F514, 2013.
58. Shirley DG, Walter MF, Keeler BD, Waters NJ, Walter SJ. Selective blockade of oxytocin and vasopressin V(1a) receptors in anaesthetised rats: evidence that activation of oxytocin receptors rather than V(1a) receptors increases sodium excretion. Nephron Physiol 117: p21-p26, 2011.
59. Stridh S, Palm F, Hansell P. Renal interstitial hyaluronan: functional aspects during normal and pathological conditions. Am J Physiol Regul Integr Comp Physiol 302: R1235-R1249, 2012.
60. Suzuki S, Yoshihisa A, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Abe Y, Saito T, Ohwada T, Suzuki H, Saitoh S, Kubota I, Takeishi Y Acute heart failure volume control multicenter randomized (AVCMA) trial: comparison of tolvaptan and carperitide. J Clin Pharmacol 53: 1277-1285, 2013.
61. Takenaka T, Mitchell KD, Navar LG. Contribution of angiotensin II to renal hemodynamic and excretory responses to nitric oxide synthesis inhibition in the rat. J Am Soc Nephrol 4: 1046-1053, 1993.
62. Teerlink JR, Gray GA, Clozel M, Clozel JP. Increased vascular responsiveness to norepinephrine in rats with heart failure is endothelium dependent. Dissociation of basal and stimulated nitric oxide release. Circulation 89: 393-401, 1994.
63. Thanakornyothin N, Susin M, Benoff S, Wilkes BM. Increased rennin immunostaining in preglomerular arterioles after myocardial infarction in the rat. J Lab Clin Med 137: 21-27, 2001.
64. Thomson SC, Deng A, Wead L, Richter K, Blantz RC, Vallon V. An unexpected role for angiotensin II in the link between dietary salt and proximal reabsorption. J Clin Invest 116: 1110-1116, 2006.
65. Uhrenholt TR, Schjerning J, Hansen PB, Norregaard R, Jensen BL, Sorensen GL, Skott O. Rapid inhibition of vasoconstriction in renal afferent arterioles by aldosterone. Circ Res 93: 1258-1266, 2003.
66. Vallon V, Miracle C, Thomson S. Adenosine and kidney function: potential implications in patients with heart failure. Eur J Heart Failure 10: 176-187, 2008.
67. Vallon V, Rieg T. Regulation of renal NaCl and water transport by the ATP/UTP/P2Y2 receptor system. Am J Physiol Renal Physiol 301: F463-F475, 2011.
68. Weihprecht H, Lorenz JN, Briggs JP, Schnermann J. Vasoconstrictor effect of angiotensin and vasopressin in isolated rabbit afferent arterioles. Am J Physiol Renal Fluid Electrolyte Physiol 261: F273-F282, 1991.
69. Welch WJ. Adenosine type 1 receptor antagonists in fluid retaining disorders. Expert Opin Investig Drugs 11: 1553-1562, 2002.
70. Witty RT, Davis JO, Shade RE, Johnson JA, Prewitt RL. Mechanisms regulating renin release in dogs with thoracic caval constriction. Circ Res 31: 339-347, 1972.
71. Zhang Q, Lin L, Lu Y, Liu H, Duan Y, Zhu X, Zou C, Manning RD Jr, Liu R. Interaction between nitric oxide and superoxide in the macula densa in aldosterone-induced alterations of tubuloglomerular feedback. Am J Physiol Renal Physiol 304: F326-F332, 2013.
72. Zou AP, Fleming JT, Falck JR, Jacobs ER, Gebremedhin D, Harder DR, Roman RJ. 20-HETE is an endogenous inhibitor of the large-conductance Ca2-activated K channel in renal arterioles. Am J Physiol Regul Integr Comp Physiol 270: R228-R237, 1996.